Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.91 Billion | USD 7.38 Billion | 16.2% | 2024 |
The global cannabis testing market size was worth around USD 1.91 Billion in 2024 and is predicted to grow to around USD 7.38 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 16.2% between 2025 and 2034.
The report analyzes the global cannabis testing market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cannabis testing industry.
Cannabis testing is the process of analyzing a single sample of cannabis to evaluate CBD, THC, and terpene levels, as well as pollutants and impurities such as mold spores, residual solvents, infection, and pesticide residue. Each state and municipality has the authority to set their own rules and regulations for what must be tested and printed on cannabis labeling.
Individual producers may also choose to adhere to more severe guidelines, even having their samples tested for CBG and CBC levels. Only qualified chemists and lab workers are permitted to conduct this testing. Cannabis production and sales were formerly prohibited worldwide for numerous years.
Cannabis is a type of psychoactive drug that has recreational and medicinal uses. Cannabis mainly consists of THC (tetrahydrocannabinol) that causes changes in perception, increases appetite and sensation of euphoria. There are different types of cannabis, such as topical cannabis, inhaling cannabis, solid edible cannabis, and liquid edible cannabis, which are tested during the cannabis testing procedure.
The market is fostering medical cannabis legalization and increasing cannabis testing labs
Medical cannabis has shown to be helpful in a number of medical uses, including lowering intraocular pressure in glaucoma patients, managing muscular spasms in multiple sclerosis patients, boosting appetite in AIDS patients, and minimizing chemotherapy-induced nausea. Medical cannabis is legal in a number of countries due to its health benefits. Italy, Brazil, Israel, the Netherlands, Germany, the United Kingdom, Portugal, Spain, North Korea, Canada, and Australia have all approved it in the last few years.
Furthermore, 25 states in the United States legalized medical cannabis, with four states—Alaska, Oregon, Washington, and Colorado legalizing cannabis for use for both recreational and medical purposes. Thus, with the rising legalization of cannabis, an increase in adoption of its testing is been witnessed which in turn is fostering the growth of the global cannabis testing market. In addition to this, the increasing number of cultivators and the growing necessity for the safety & efficacy of cannabis products are also some of the key factors that are fueling the market growth.
The increase in the use of medical cannabis for various applications, such as reduction of nausea caused after chemotherapy, stimulation of appetite in patients suffering from AIDS, and controlling of muscle spasms, is fueling the demand for cannabis globally. This increase in demand has led to the legalization of cannabis by governments in various countries. For instance, Australia legalized medical cannabis in 2016, which is fuelling the growth of the global cannabis testing market. The rise in adoption of the cannabis software namely LIMS in the cannabis testing labs and the rise in the number of awareness programs such as workshops and conferences in various countries is also driving the global market for cannabis testing. However, the high cost of instruments and the lack of skilled professionals are hampering the development of the global cannabis testing market.
The cannabis testing market may be hampered by a lack of universal testing standards.
For delivering a precise and accurate dose of cannabis for medical purposes, certain standards of quality control and regulation are essential. There is, however, a lack of consistency in quality standards among countries. For example, different states in the United States have varied rules and variances governing medical and adult-use cannabis. Various states have different possession limits. The wide range of legislation governing the use of medical cannabis presents a considerable problem for testing laboratories when assessing the quality of these products. Such disparities between states in the United States and between European countries may stymie business growth.
Growing necessity of heavy metal testing for cannabis is likely to drive the market during the forecast period.
Besides pesticides, microbiological organisms, and residual solvents, heavy metals are one of the most common pollutants detected in cannabis and its derivatives. Furthermore, heavy metals are highly poisonous and can cause poisoning and other issues when exposed. As a result, heavy metal testing for cannabis and its derivatives is becoming extremely prevalent. Several government agencies have made heavy metal testing for cannabis products mandatory. All such factors coupled with the use of advanced instruments like HPLC techniques are likely to generate ample opportunities for the growth of the global cannabis testing market during the forecast period.
High cost associated with the set-up of cannabis testing laboratories acts as a major challenge for the market
One of the most critical challenges in this market is the high startup expenses for cannabis testing laboratories. These labs must invest a large amount of money in order to purchase and maintain expensive, modern analytical equipment. Accreditations & certifications such as ISO certification processes, software requirements, standardization & upgrades of equipment, and the need for qualified experts all add to the operating costs. Also, because of the ambiguity in the cannabis testing market, many banks refuse to fund or provide any other type of support to these laboratories. Furthermore, several governments are working on a plan to impose taxes on cannabis testing labs. Thus, the high cost associated with the set-up of cannabis testing laboratories poses a major challenge for the market growth.
The global cannabis testing market is divided based on technology, test type, and region.
Based on the technology, the global market is split into spectroscopy and chromatography.
By test type, the marke t is categorized into mycotoxin testing, terpene testing, heavy metal testing, residual solvent screening, pesticide screening, and potency testing.
Report Attributes | Report Details |
---|---|
Report Name | Cannabis Testing Market |
Market Size in 2024 | USD 1.91 Billion |
Market Forecast in 2034 | USD 7.38 Billion |
Growth Rate | CAGR of 16.2% |
Number of Pages | 188 |
Key Companies Covered | Thermo Fisher Scientific, MERCK KGAA, Shimadzu Corporation, Agilent Technologies Inc., PharmLabs LLC, SC Laboratories Inc., Steep Hill Inc., DigiPath Inc., GreenLeaf Lab, and CW ANALYTICAL, and others. |
Segments Covered | By Technology, By Test Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the cannabis testing market on a global and regional basis.
The global cannabis testing market is dominated by players like:
By Technology
By Test Type
By Region
FrequentlyAsked Questions
Leading players in the global cannabis testing market include Thermo Fisher Scientific, MERCK KGAA, Shimadzu Corporation, Agilent Technologies Inc., PharmLabs LLC, SC Laboratories Inc., Steep Hill Inc., DigiPath Inc., GreenLeaf Lab, and CW ANALYTICAL, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed